ArticleToxins2023

Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine.

Giulia Ceccardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.